AstraGin
Commercial- Indications
- Nutrient absorption, Cardiovascular health
Company intelligence / Profile preview
NuLiv Science has published preclinical and human trial data supporting the efficacy of its key proprietary ingredients. For example, AstraGin® demonstrated significant improvements in gut barrier integrity and beneficial microbiota growth in a human clinical trial with ulcerative colitis patients. Senactiv® has shown benefits for muscle energy/preservation via senescent cell clearance in both animal models and humans. InnoSlim® supports healthy weight management through effects on glucose transporters validated by preclinical/human studies. These results position their products as evidence-based solutions within the supplement industry.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NuLiv Science.